Cellectar Biosciences Inc (CLRB)
0.2402
-0.02
(-7.62%)
USD |
NASDAQ |
Dec 16, 15:16
Cellectar Biosciences Total Liabilities (Quarterly): 22.13M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.419B |
| Ligand Pharmaceuticals Inc | 113.69M |
| Revance Therapeutics Inc | 624.59M |
| Zymeworks Inc | 120.17M |
| Applied Therapeutics Inc | 100.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.29M |
| Shareholders Equity (Quarterly) | 15.16M |